Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Karmanos Cancer Institute Resource Report Resource Website |
Karmanos Cancer Institute (RRID:SCR_000508) | Karmanos | data or information resource, portal | Center for patient care, education and research on cancer. The institute focuses its research on prevention methods, early detection, treatment and finding cures. | cancer, research, education, prevention, early detection, treatment, patient, care |
has parent organization: Wayne State University; Michigan; USA is parent organization of: JP McCarthy Cord Stem Cell Bank |
Cancer | NCI | Public | nlx_143656 | SCR_000508 | Karmanos Cancer Center, Barbara Ann Karmanos Cancer Institute, Barbara Ann Karmanos Cancer Center | 2026-08-29 11:28:38 | 0 | |||||
|
DCTD Resource Report Resource Website 10+ mentions |
DCTD (RRID:SCR_004196) | DCTD | data or information resource, funding resource, portal | Division of NCI that takes prospective cancer detection and treatment leads, facilitates their paths to clinical application, and expedites the initial and subsequent large-scale testing of new agents, biomarkers, imaging tests, and other therapeutic interventions (radiation, surgery, immunotherapy) in patients. DCTD, like all of NCI, supports many programs that could not be done without government funding - investigators supported by the division engage in scientifically sound, high-risk research that may yield great benefits for patients with cancer, but are too difficult or risky for industry or academia to pursue. This includes a particular emphasis on the development of distinct molecular signatures for cancer, refined molecular assays, and state-of-the-art imaging techniques that will guide oncologic therapy in the future. The division has eight major programs that work together to bring unique molecules, diagnostic tests, and therapeutic interventions from the laboratory bench to the patient bedside: * Cancer Diagnosis Program * Cancer Imaging Program * Cancer Therapy Evaluation Program * Developmental Therapeutics Program * Radiation Research Program * Translational Research Program * Biometrics Research Branch * Office of Cancer Complementary and Alternative Medicine | treatment, diagnosis, molecule, diagnostic test, therapeutic intervention |
is listed by: OMICtools has parent organization: National Cancer Institute is parent organization of: CDP |
Cancer | NCI | OMICS_01537 | SCR_004196 | Division of Cancer Treatment and Diagnosis | 2026-08-29 11:28:35 | 20 | ||||||
|
National Genome Research Network Resource Report Resource Website 10+ mentions |
National Genome Research Network (RRID:SCR_006626) | NGFN | data or information resource, organization portal, portal | The program of medical genome research is a large-scale biomedical research project which extends the national genome research net (NGFN) and will be funded by the federal ministry of education and research (BMBF) from 2008-2013. Currently the program includes two fields: * Research ** NGFN-Plus: With the aim on combating diseases that are central to health policy, several hundred researchers are systematically investigating the complex molecular interactions of the human body. They are organized in 26 Integrated Genome Research Networks. * Application ** NGFN-Transfer: The rapid transfer of results from medical genome research into medical and industrial application is the aim of the scientists from research institutes and biomedical enterprises that cooperate in eight Innovation Alliances. AREAS OF DISEASE * Cardiovascular disease * Cancer * Neuronal diseases * Infections and Inflammations * Environmental factors | genome, research, gene, disease | Cardiovascular disease, Cancer, Neuronal disease, Infectious disease, Inflammation, Disease linked to environment | BMBF | nlx_151595 | SCR_006626 | NGFN - National Genome Research Network, German National Genome Research Network | 2026-08-29 11:28:37 | 26 | |||||||
|
Central England Haemato-Oncology Research Biobank Resource Report Resource Website |
Central England Haemato-Oncology Research Biobank (RRID:SCR_004637) | CEHRB | biomaterial supply resource, cell repository, material resource | The Central England Haemato-Oncology Research Biobank stores excess material from oncology samples referred for diagnostic testing and disease monitoring at the West Midlands Regional Genetics Laboratory (WMRGL). The bank is housed within the WMRGL. Types of material stored include viable cells, fixed cell suspensions, DNA, RNA / cDNA, and plasma. The material is made available to all cancer research groups both locally and nationally. Excess sample (mainly from blood and bone marrow) is stored from diagnostic patient material and from samples received throughout their disease course. The WMRGL serves a population of about 5.5 million and is the largest UK NHS genetic Lab. Due to the large patient population CEHRB is able to collate sufficient research material from all classifications of neoplastic haematological disorders including those that are rare. | rare, ontology, hematology, tumor, oncology | is listed by: One Mind Biospecimen Bank Listing | Cancer, Neoplastic hematological disorder | Public: The material is made available to all cancer research groups both locally and nationally. | nlx_63387 | http://www.bwhct.nhs.uk/genetics-index/reglab_oncology.htm, http://www.bwhct.nhs.uk/genetics-index/central_england_haemato-oncology_research_biobank.htm | SCR_004637 | Central England Haemato-Oncology Research Biobank (CEHRB) | 2026-08-29 11:28:38 | 0 | |||||
|
Wistar Institute Collection at Coriell Resource Report Resource Website |
Wistar Institute Collection at Coriell (RRID:SCR_004660) | Wistar Collection | biomaterial supply resource, cell repository, material resource | Collection of cell lines developed by Wistar scientists that includes a group of hybridomas that produce monoclonal antibodies that are useful in influenza research and vaccine development, melanoma cell lines derived from patients with diseases ranging from mild dysplasia to advanced metastatic cancer and a range of human endothelial cell lines. | hybridoma, monoclonal antibody, antibody, cell line, melanoma cell line, endothelial cell line, smooth muscle cell line, disease, cancer, dysplasia, metastatic cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Coriell Cell Repositories has parent organization: Wistar Institute |
Disease, Cancer, Dysplasia, ( Diseases ranging from mild dysplasia to advanced metastatic cancer ) | Non-commercial, For research conducted by universities, Government agencies and academic research centers, Commercial with license | nlx_143856 | SCR_004660 | 2026-08-29 11:28:35 | 0 | |||||||
|
Strelka2 Resource Report Resource Website 100+ mentions |
Strelka2 (RRID:SCR_005109) | software resource, source code | Software for somatic single nucleotide variant (SNV) and small indel detection from sequencing data of matched tumor-normal samples. Strelka2 germline and somatic small variant caller. | single nucleotide variant, indel, somatic snv, next-generation sequencing, bio.tools |
is listed by: Debian is listed by: bio.tools is listed by: SoftCite has parent organization: Illumina |
Cancer, Tumor, Normal | PMID:22581179 PMID:30013048 |
Free, Available for download, Freely available | biotools:strelka | https://bio.tools/strelka, https://sources.debian.org/src/strelka/ | http://bioinformatics.oxfordjournals.org/content/early/2012/05/10/bioinformatics.bts271.full.pdf | SCR_005109 | Strelka | 2026-08-29 11:31:54 | 283 | ||||
|
Herzon Lab Resource Report Resource Website |
Herzon Lab (RRID:SCR_008850) | Herzon Lab | access service resource, core facility, service resource | My laboratory has created a family of natural product-inspired anticancer agents. We have evaluated our compounds at the Yale Center for Chemical Genomics, and they are exhibiting IC50 values in the low nM range against K562, HeLa, LnCAP, and HCT-116 lines. Their mechanism of action is unknown, although the natural products have been shown to cleave DNA. An evaluation of the natural products at the NCI has shown that they have a toxicity profile that is distinct from other known DNA damaging agents. We can readily access gram-quantities of these agents for further studies. We are looking for researchers who might find these compounds useful in medicinal applications, for example, for treatment of a specific cancer. We are capable of synthesizing new analogs, such as those incorporating a specific recognition or targeting element, and would be excited to pursue this avenue of research. | chemistry, synthetic anticancer agent, anticancer agent | has parent organization: Yale University; Connecticut; USA | Cancer | nlx_149076 | SCR_008850 | Herzon Laboratory | 2026-08-29 11:32:11 | 0 | |||||||
|
Laser Biomedical Research Center Resource Report Resource Website 1+ mentions |
Laser Biomedical Research Center (RRID:SCR_000106) | LBRC | access service resource, biomedical technology research center, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 31,2025. Biomedical technology research center that develops basic scientific understanding and new techniques required for advancing clinical applications of lasers and spectroscopy. LBRC merges optical spectroscopy, imaging, scattering, and interferometry techniques to study biophysics and biochemistry of healthy and diseased biological structures from subcellular to entire-organ scale. | spectroscopy, laser, biomedicine, optical spectroscopy, imaging, scattering, interferometry, optical probe, microscopy | has parent organization: Massachusetts Institute of Technology; Massachusetts; USA; | Pre-cancer, Cancer, Atherosclerosis, Healthy, Diseased | NIBIB 4P41EB015871-30 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_152645 | SCR_000106 | MIT Laser Biomedical Research Center, Laser Biomedical Research Center (LBRC) | 2026-08-29 11:31:42 | 4 | |||||
|
Center for In Vivo Microscopy Resource Report Resource Website 10+ mentions |
Center for In Vivo Microscopy (RRID:SCR_001426) | CIVM | biomedical technology research center, training resource | Biomedical technology research center dedicated to the development of novel imaging methods for the basic scientist and the application of the methods to important biomedical questions. The CIVM has played a major role in the development of magnetic resonance microscopy with specialized MR imaging systems capable of imaging at more than 500,000x higher resolution than is common in the clinical domain. The CIVM was the first to demonstrate MR images using hyperpolarized 3He which has been moved from mouse to man with recent clinical trials performed at Duke in collaboration with GE. More recently the CIVM has developed the molecular imaging workbench---a system dedicated to multimodality cardiopulmonary imaging in the rodent. Their collaborators are employing these unique imaging systems in an extraordinary range of mouse and rat models of neurologic disease, cardiopulmonary disease and cancer to illuminate the underlying biology and explore new therapies. | imaging, magnetic resonance microscopy, magnetic resonance imaging, clinical, mri, ct, x-ray, ultrasound, confocal, optical, spect | has parent organization: Duke University; North Carolina; USA | Cardiopulmonary disease, Cancer, Neurological disease | NIBIB 4P41EB015897-27 | Free, Freely Available | nlx_152650 | SCR_001426 | Duke Center for In Vivo Microscopy | 2026-08-29 11:31:42 | 10 | |||||
|
GSE4922 Resource Report Resource Website 100+ mentions |
GSE4922 (RRID:SCR_003557) | GSE4922 | data or information resource, data set | Curated data set of a study that investigated the expression profiles of 347 primary invasive breast tumors on Affymetrix microarrays. Three separate breast cancer cohorts were analyzed: 1) Uppsala (n=249), 2) Stockholm (n=58), 3) Singapore (n=40). The Uppsala and Singapore data can be accessed in GSE4922. The Stockholm cohort data can be accessed at GEO Series GSE1456. | adult human, expression profile, breast |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Breast cancer, Tumor | Free, Public | nlx_157796 | SCR_003557 | 2026-08-29 11:31:55 | 111 | |||||||
|
United States Cancer Statistics Public Information Data Resource Report Resource Website 1+ mentions |
United States Cancer Statistics Public Information Data (RRID:SCR_024896) | data or information resource, disease-related portal, portal, topical portal | United States Cancer Statistics public information data provided by Centers for Disease Control and Prevention. | Centers for Disease Control, cancer statistics, USA, public information, | cancer | Free, Freely available | SCR_024896 | 2026-08-29 11:33:47 | 1 | ||||||||||
|
Confederation of Cancer Banks Resource Report Resource Website |
Confederation of Cancer Banks (RRID:SCR_006885) | CCB | biomaterial supply resource, material resource | The Confederation of Cancer Biobanks (CCB) is a consortium of organisations based in the UK that are involved in the development, management and use of biobank resources for cancer research. The Confederation aims to promote and disseminate a collective view on best practices for biobanks and to promote transfer of knowledge and experiences between banks. While individual banks retain their full autonomy, membership leads to mutual benefit, ensures complementarities, avoids unnecessary competition and ensures a coordinated approach to cancer biosample provision. This will benefit all involved by allowing the sharing of expertise and information, the establishment of harmonized standards for the operation of cancer biobanks and provide a means to access a larger pool of biosamples from the confederated banks. The initial achievements of the NCRI Confederation of Cancer Biobanks were the drafting of a Memorandum of Understanding for the founder members of the Confederation, and a document outlining the Guiding Principles for the management and operation of a tissue bank / biobank in the contemporary ethical and legal setting. Any organization based in the UK, which collects and distributes biosamples for cancer research (not necessarily in the UK), may apply to join. CCB Members receive: * access to the Members Area of the web site containing shared resources * inclusion in email discussion fora with other members * networking opportunities with other members * inclusion in a collective voice to research funders, policy makers, legislators and others * inclusion in the NCRI''s new on-line sample directory * one free registration for each CCB workshop * a future opportunity to pursue accreditation/quality endorsement for the bank * a potential future opportunity for your donors to join a donor forum, which provides patients/sample donors with a mechanism of keeping in touch with research biobanking activities. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: onCore UK |
Cancer | nlx_44213 | SCR_006885 | NCRI CCB, NCRI Confederation of Cancer Biobanks, National Cancer Research Institute''s Confederation of Cancer Biobanks | 2026-08-29 11:30:48 | 0 | ||||||||
|
Saint-Luc Tumour Bank Resource Report Resource Website 1+ mentions |
Saint-Luc Tumour Bank (RRID:SCR_008714) | Saint-Luc Tumor Bank | biomaterial supply resource, material resource | When a patient suffering or thought to be suffering from cancer is cared for, samples are often taken to determine the precise diagnosis and to determine any treatment necessary. After this essential stage of the patient''s care, unused biological material is sometimes left over. This material is an essential and precious tool for research into cancer. For this reason, patients can decide to make the material available to researchers the world over who study either the development mechanism of cancer or the new treatments available. Residual samples are centralized and stored in the Tumor Bank at the Cliniques Universitaires Saint-Luc Cancer Centre. The research carried out on this material primarily benefits cancer patients. It can help improve existing treatments or discover new drugs, and also allows new diagnostic tools to be tested. Any financial profits obtained from assessing the results obtained are entirely reinvested in the work of the Cancer Centre''s Tumour Bank and in new research projects at the Catholic University of Louvain. Using and sharing material, and verification and retrospective analysis of clinical data, all comply with strict rules. As with donations of blood, marrow or organs, an Ethics Committee oversees the operations of the Tumour Bank and research projects. This committee is responsible for ensuring compliance with current Belgian and legal texts, especially those concerning the protection of patient privacy and rights. | clinical data, tumor, cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Cliniques Universitaires Saint-Luc Cancer Centre |
Tumor, Cancer | Public?: This material can be made available to researchers the world over who study either the development mechanism of cancer or the new treatments available. Any financial profits obtained from assessing the results obtained are entirely reinvested in the work of the Cancer Centre''s Tumour Bank and in new research projects at the Catholic University of Louvain. | nlx_12735 | SCR_008714 | Cliniques Universitaires Saint-Luc Cancer Center Tumor Bank, Saint-Luc Cancer Centre Tumour Bank, Saint-Luc Biobank or Tumour Bank, Cliniques Universitaires Saint-Luc Cancer Centre Tumour Bank | 2026-08-29 11:30:51 | 1 | ||||||
|
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Scientific Imaging Resource Report Resource Website |
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Scientific Imaging (RRID:SCR_015340) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on July 27,2022. Scientific imaging service that serves as a centralized facility for imaging and visualization. The core facility provides access to time lapse and 3-D microscopy and quantitative autoradiography. | scientific imaging service, imaging, visualization, time lapse, 3d microscopy, autoradiography |
is listed by: NIDDK Information Network (dkNET) has parent organization: Fred Hutchinson Cancer Center is organization facet of: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology |
cancer | NIDDK P30DK056465 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015340 | 2026-08-29 11:32:56 | 0 | ||||||||
|
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Comparative Medicine Resource Report Resource Website |
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Comparative Medicine (RRID:SCR_015326) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on July 27,2022. Core facility that provides a variety of animal housing, veterinary and research support services. | comparative medicine, animal housing, veterinanary resource |
is listed by: NIDDK Information Network (dkNET) has parent organization: Fred Hutchinson Cancer Center is organization facet of: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology |
cancer | NIDDK P30DK056465 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015326 | 2026-08-29 11:32:55 | 0 | ||||||||
|
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Genomics Shared Resource Resource Report Resource Website |
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Genomics Shared Resource (RRID:SCR_015327) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on July 27,2022. Core facility that provides expertise and support for generating genomics-based data. Services for DNA arrays, genetic analysis, and high-throughput screening are provided through three specialized laboratories. | genomics core, dna array services, genetic analysis services, high throughput screening services |
is listed by: NIDDK Information Network (dkNET) has parent organization: Fred Hutchinson Cancer Center is organization facet of: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology |
cancer | NIDDK P30DK056465 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015327 | 2026-08-29 11:32:56 | 0 | ||||||||
|
NIH NCI list of FDA approved cancer drugs Resource Report Resource Website 10+ mentions |
NIH NCI list of FDA approved cancer drugs (RRID:SCR_021841) | data or information resource, disease-related portal, portal, topical portal | Portal to find consumer friendly information about drugs for cancer and conditions related to cancer. The list is in alphabetical order by generic name and brand name. | drugs for cancer, conditions related to cancer, alphabetical order, generic name, brand name | cancer | Free, Available for download, Freely available | SCR_021841 | 2026-08-29 11:27:18 | 16 | ||||||||||
|
TumorSim Resource Report Resource Website 1+ mentions |
TumorSim (RRID:SCR_002604) | simulation software, software application, software resource | Simulation software that generates pathological ground truth from a healthy ground truth. The software requires an input directory that describes a healthy anatomy (anatomical probabilities, mesh, diffusion tensor image, etc) and then outputs simulation images. | clinical neuroinformatics, magnetic resonance, mri, brain, segmentation, simulation, tumor, ground truth |
uses: BrainWeb - Simulated Brain Database is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) has parent organization: University of Utah; Utah; USA |
Cancer | NIBIB R01 EB000219 | PMID:19119055 | Free, Available for download, Freely available | nlx_156007 | SCR_002604 | 2026-08-29 11:27:38 | 1 | ||||||
|
SEER Datasets and Software Resource Report Resource Website 10+ mentions |
SEER Datasets and Software (RRID:SCR_003293) | data or information resource, disease-related portal, portal, software resource, topical portal | Portal provides SEER research data and software SEER*Stat and SEER*Prep. SEER incidence and population data associated by age, sex, race, year of diagnosis, and geographic areas can be used to examine stage at diagnosis by race/ethnicity, calculate survival by stage at diagnosis, age at diagnosis, and tumor grade or size, determine trends and incidence rates for various cancer sites over time. SEER releases new research data every Spring based on the previous November’s submission of data. | NCI, cancer, statistics, epidemiology, analysis |
lists: SEER*Stat lists: NCI SEER Cancer Stage Variable Documentation is related to: Surveillance Epidemiology and End Results has parent organization: National Cancer Institute |
cancer | NCI | Free, Freely available | nif-0000-31490 | SCR_003293 | The Surveillance Epidemiology and End Results (SEER) Program, SEER Datasets Software, SEER Datasets & Software, The Surveillance Epidemiology and End Results (SEER) Program of the National Cancer Institute | 2026-08-29 11:27:32 | 28 | ||||||
|
FireBrowse Resource Report Resource Website 100+ mentions |
FireBrowse (RRID:SCR_026320) | data or information resource, disease-related portal, portal, topical portal | Portal provides access to cancer genomic data from variety of analyses: clinical, copy number, miR, miRseq, mRNA, mRNAseq, mutation and pathway analyses. Provides comprehensive suite of interdependent analyses of those data, including: correlations, clustering, and GISTIC and MutSigCV. Companion portal to the Broad Institute GDAC Firehose analysis pipeline, and was developed to cull and analyze data generated by The Cancer Genome Atlas (TCGA), which characterizes and identifies genomic patterns in human cancer models. | cancer genomics data, clinical annotations, DNA copy number, miR, miRseq, mRNA, mRNAseq, analyze data, |
has parent organization: Broad Institute works with: The Cancer Genome Atlas works with: Broad Institute GDAC Firehose |
cancer | Free, Freely available, | http://firebrowse.org/tutorial/FireBrowse-Tutorial.pdf, | SCR_026320 | 2026-08-29 11:34:42 | 131 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.